Article Details
Retrieved on: 2022-03-14 05:59:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New Delhi: AstraZeneca and MSD's Lynparza (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated ...
Article found on: medicaldialogues.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here